OCGN · Ocugen Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 0.75 USD |
|---|---|
| 1-day change | +2.8% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 13 / 12 / 20 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 8 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +6.5% |
| Sales growth Q/Q | -111.0% |
| Distance from 52-week high | +70.0% |
| Market cap (USD) | $547.6M |